Pinsent Masons advises Straumann on investment in DrSmile

14 Jul 2020 | 12:52 pm |

Pinsent Masons has advised the Straumann Group on its acquisition of a significant majority stake in DrSmile – a leading dental provider of orthodontic treatment solutions in Germany.

Headquartered in Basel, Straumann will acquire a majority stake in DrSmile and has committed to substantial further investment to finance future growth until the acquisition is complete. The parties have agreed on a call/put option mechanism for the remaining stake and an earn-out-based consideration. DrSmile has established itself with its Clear Aligner business as a dental brand for modern dental corrections throughout Europe since its foundation in 2017. The Berlin-based start-up will remain operationally independent. The closing of this transaction is expected in the third quarter of 2020. Straumann will benefit from DrSmile's expertise in DTC (direct-to-consumer) marketing to expand its clear aligner business.

The deal was led by Dr. Torsten Bergau and a team of advisors including Dr. Sandra Schuh. Dr. Torsten Bergau said, "This is a significant deal for the Straumann Group that strengthens its profile as a world leading providers of dental prosthetics and orthodontic solutions. This transaction also continues to build on the firm's credentials in the dental sector across mergers and acquisitions as well as regulation, employment, data privacy, cyber security and intellectual property."

The firm regularly advises Straumann and has assisted clients in the dental industry for more than 10 years. With more than 25 lawyers, Pinsent Masons' pan-European dental group advises companies in the industry on the current challenges posed by digitalization, consolidation and new distribution channels.

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons appoints employment partner in Dublin

Multinational law firm Pinsent Masons has enhanced its employment law capabilities with the appointment of Dublin-based Deirdre Lynch to lead the firm’s employment teams in Ireland and Northern Ireland.

Pinsent Masons announces new co-heads of Madrid, Inmaculada Castelló and Fernando Gutiérrez

Multinational law firm Pinsent Masons has appointed Inmaculada Castelló and Fernando Gutiérrez as co-heads of the Madrid office as of 1 September 2022.

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe

Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.

Pinsent Masons advises on landmark financing of FINN

Multinational law firm Pinsent Masons has advised French investment company Korelya Capital on the EUR 100+ million financing of car subscription start-up FINN.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts